Evidence map›Paper›PMID 37207203›Full record

ArticleFrontiers in immunology2023

Cell membrane-bound toll-like receptor-1/2/4/6 monomers and -2 heterodimer inhibit enterovirus 71 replication by activating the antiviral innate response.

Ping-Ping Sun, Dan Li, Meng Su, Qing Ren, Wen-Ping Guo, Jiang-Li Wang, Luan-Ying Du, Guang-Cheng Xie

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Frontiers in immunology · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ping-Ping SunDepartment of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.
Dan LiDepartment of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.
Meng SuDepartment of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.
Qing RenDepartment of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.
Wen-Ping GuoDepartment of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.
Jiang-Li WangDepartment of Microbiology Laboratory, Chengde Center for Disease Control and Prevention, Chengde, Hebei, China.
Luan-Ying DuDepartment of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.
Guang-Cheng XieDepartment of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.
Chengde Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Host immune activation is critical for enterovirus 71 (EV71) clearance and immunopathogenesis. However, the mechanism of innate immune activation, especially of cell membrane-bound toll-like receptors (TLRs), against EV71 remains unknown. We previously demonstrated that TLR2 and its heterodimer inhibit EV71 replication. In this study, we systematically investigated the effects of TLR1/2/4/6 monomers and TLR2 heterodimer (TLR2/TLR1, TLR2/TLR6, and TLR2/TLR4) on EV71 replication and innate immune activation. We found that the overexpression of human- or mouse-derived TLR1/2/4/6 monomers and TLR2 heterodimer significantly inhibited EV71 replication and induced the production of interleukin (IL)-8 via activation of the phosphoinositide 3-kinase/protein kinase B (

Indexed as

Enterovirus A, HumanToll-Like Receptor 1AnimalsCapsid ProteinsCell MembraneHumansMicePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktToll-Like Receptor 2Toll-Like Receptor 4Toll-Like Receptor 6Toll-Like ReceptorsCapsid ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktToll-Like Receptor 1Toll-Like Receptor 2Toll-Like Receptor 4Toll-Like Receptor 6Toll-Like Receptorsantiviral innate immunitycapsid proteinsenterovirus 71immune activationtoll-like receptors

Identifiers

PMID37207203
PMCPMC10189127
OpenAlexW4367845200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.